Acceder

Publicaciones - ONCOLOGÍA CLÍNICA Y TRASLACIONAL

Cargando...
Boegemann M, Bennamoun M, Dourthe LM, Encarnacion JA, Hegele A, Hellmis E, Latorzeff I, Leicht W, Onate-Celdran J, Rosino-Sanchez A, Hanna K, Lencart J, Lukac M, Schioppa CA, Van Sanden S, Kramer G. Final analysis of ArtemisR, a European real-world retrospective study of apalutamide for the treatment of patients with metastatic hormone-sensitive prostate cancer. BMC Cancer. 2025 Jul 1;25(1):1119. doi: 10.1186/s12885-025-14294-7. PubMed PMID: 40597879; PubMed Central PMCID: PMC12211757.
AÑO: 2025; IF: 3.4
40597879
de Bono JS, Williams A, Melero I, Jayaram A, Hawley JE, Doger de Speville B, Moreno I, Castellano D, Reig O, Knapen DG, Anguera G, Martinez J, Gort E, de Jonge M, Alonso-Romero JL, Boni V, Perez-Gracia JL, Falcon A, de Groot DJ, Pierce AJ, Leishman AJ, Lloyd P, Bartlett PD, Bland-Ward P, Chau A, Song M, Duffy K, Hashimoto K, de Vries E. A phase I dose escalation and cohort expansion study of CB307, a trispecific Humabody(R) against PSMA, CD137, and albumin in patients with PSMA-positive solid tumors. Clin Cancer Res. 2025 Mar 17. doi: 10.1158/1078-0432.CCR-24-3581. Online ahead of print. PubMed PMID: 40094417.
AÑO: 2025; IF: 10.0
40094417
Encarnacion Navarro JA, Morillo Macias V, Borras Calbo M, De la Fuente Munoz I, Lozano Martinez A, Garcia Martinez V, Fernandez Fornos L, Guijarro Roche M, Amr Rey O, Garcia Gomez R. Multicenter Real-World Study: 432 Patients with Apalutamide in Metastatic Hormone-Sensitive Prostate Cancer. Curr Oncol. 2025 Feb 21;32(3):119. doi: 10.3390/curroncol32030119. PubMed PMID: 40136324; PubMed Central PMCID: PMC11941571.
AÑO: 2025; IF: 2.8
40136324
Royo-Villanova M, Minambres E, Sanchez JM, Torres E, Manso C, Ballesteros MA, Parrilla G, de Paco Tudela G, Coll E, Perez-Blanco A, Dominguez-Gil B. Maintaining the permanence principle of death during normothermic regional perfusion in controlled donation after the circulatory determination of death: Results of a prospective clinical study. Am J Transplant. 2024 Feb;24(2):213-221. doi: 10.1016/j.ajt.2023.09.008. Epub 2023 Sep 20. PubMed PMID: 37739346.
AÑO: 2024; IF: 8.9
37739346
Li X, Zhang Y, Zhu C, Xu W, Hu X, Martinez DAS, Romero JLA, Yan M, Dai Y, Wang H. Circulating blood biomarkers correlated with the prognosis of advanced triple negative breast cancer. BMC Womens Health. 2024 Jan 13;24(1):38. doi: 10.1186/s12905-023-02871-6. PubMed PMID: 38218823; PubMed Central PMCID: PMC10787989.
AÑO: 2024; IF: 2.4
38218823
< AnteriorSiguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

ONCOLOGÍA CLÍNICA Y TRASLACIONAL